Cite
MLA Citation
S.‐M. Jin et al.. “Lobeglitazone and pioglitazone as add‐ons to metformin for patients with type 2 diabetes: a 24‐week, multicentre, randomized, double‐blind, parallel‐group, active‐controlled, phase III clinical trial with a 28‐week extension.” Diabetes, obesity & metabolism, vol. 17, no. 6, n.d., pp. 599–602. http://access.bl.uk/ark:/81055/vdc_100109091253.0x000013